Venture
Conexeu Sciences Inc.
Latest Form D 2026-09-29- CIK 2066836
- State NV
- Biotechnology
- 17 Form D offerings since 2025-05-09
- Total sold
- $7.7M
- across 17 offerings
- Rounds
- 17
- Form D offerings since 2025-05-09
- Latest round
- $30.9K
- 2026-09-29 · 021-599248
- Investors
- 2
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2026-09-29 · $30.9K
- 2025-05-09$1.3M021-545611
- 2025-06-13$1.7K021-548921
- 2025-11-13$2.9M021-563829
- 2025-11-20$202K021-564600
- 2026-02-04$810K021-572364
- 2026-02-27$0.5K021-574901
- 2026-03-23$44.7K021-577255
- 2026-04-01$1.8M021-578656
- 2026-05-21$0.5K021-584842
- 2026-05-21$44.7K021-584843
- 2026-06-10$22.9K021-586895
- 2026-06-30$0.2K021-589044
- 2026-06-30$86.3K021-589046
- 2026-07-31$62.7K021-592754
- 2026-08-31$88.5K021-595920
- 2026-09-15$252K021-597545
- 2026-09-29$30.9K021-599248
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($2.9M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-599248 | First filed2026-09-29 | Latest2026-09-29 | Sought$30.9K | Sold$30.9K | Investors2 | Exemptions506(b) |
| 021-597545 | First filed2026-09-15 | Latest2026-09-15 | Sought$252K | Sold$252K | Investors2 | Exemptions506(b) |
| 021-595920 | First filed2026-08-31 | Latest2026-08-31 | Sought$88.5K | Sold$88.5K | Investors3 | Exemptions506(b) |
| 021-592754 | First filed2026-07-31 | Latest2026-07-31 | Sought$62.7K | Sold$62.7K | Investors2 | Exemptions506(b) |
| 021-589046 | First filed2026-06-30 | Latest2026-06-30 | Sought$86.3K | Sold$86.3K | Investors2 | Exemptions506(b) |
| 021-589044 | First filed2026-06-30 | Latest2026-06-30 | Sought$466K | Sold$0.2K | Investors1 | Exemptions506(b) |
| 021-586895 | First filed2026-06-10 | Latest2026-06-10 | Sought$137K | Sold$22.9K | Investors1 | Exemptions506(b) |
| 021-584843 | First filed2026-05-21 | Latest2026-05-21 | Sought$44.7K | Sold$44.7K | Investors1 | Exemptions506(b) |
| 021-584842 | First filed2026-05-21 | Latest2026-05-21 | Sought$1.2M | Sold$0.5K | Investors3 | Exemptions506(b) |
| 021-578656 | First filed2026-04-01 | Latest2026-04-01 | Sought$1.8M | Sold$1.8M | Investors8 | Exemptions506(b) |
| 021-577255 | First filed2026-03-23 | Latest2026-03-23 | Sought$44.7K | Sold$44.7K | Investors1 | Exemptions506(b) |
| 021-574901 | First filed2026-02-27 | Latest2026-02-27 | Sought$1.1M | Sold$0.5K | Investors7 | Exemptions506(b) |
| 021-572364 | First filed2026-02-04 | Latest2026-02-04 | Sought$810K | Sold$810K | Investors1 | Exemptions506(b) |
| 021-564600 | First filed2025-11-20 | Latest2025-11-20 | Sought$202K | Sold$202K | Investors7 | Exemptions506(b) |
| 021-563829 | First filed2025-11-13 | Latest2025-11-13 | Sought$2.9M | Sold$2.9M | Investors5 | Exemptions506(b) |
| 021-548921 | First filed2025-06-13 | Latest2026-06-12 | Sought$2.2K | Sold$1.7K | Investors3 | Exemptions506(b) |
| 021-545611 | First filed2025-05-09 | Latest2025-07-02 | Sought$2.5M | Sold$1.3M | Investors18 | Exemptions506(b) |
Who backs Conexeu Sciences Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2026-09-29
| Name | Relationship |
|---|---|
| DAVID R BOGART | RelationshipExecutive Officer, Director |
| MILES HARRISON | RelationshipExecutive Officer, Director |
| AARON FARBERG | RelationshipDirector |
| STEPHEN D INOUYE | RelationshipExecutive Officer |
| CLAUDIA CHAVEZ-MUNOZ | RelationshipExecutive Officer |
| JEFF SHARPE | RelationshipDirector |
| Z PAUL LORENC | RelationshipDirector |
| SEBASTIAN PURCELL | RelationshipDirector |
| BRIAN PILCHER | RelationshipExecutive Officer |
| ANDREW COSTA | RelationshipDirector |
| APRIL BURKE | RelationshipDirector |
| ANA BASTIANI-POSNER | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- Nevada (NV)
- Exemptions
- Rule 506(b)
- First filed
- 2025-05-09
- Latest filing
- 2026-09-29
Who backs Conexeu Sciences Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plans
External link: SEC Filings ↗